PT Jayamas Medica Industri Tbk (IDX:OMED)
Indonesia · Delayed Price · Currency is IDR 204.00
-4.00 (-1.92%)
At close: Feb 9, 2026
IDX:OMED Revenue
PT Jayamas Medica Industri Tbk had revenue of 544.05B IDR in the quarter ending September 30, 2025, with 12.21% growth. This brings the company's revenue in the last twelve months to 1.99T, up 8.51% year-over-year. In the year 2024, PT Jayamas Medica Industri Tbk had annual revenue of 1.89T with 8.57% growth.
Revenue (ttm)
1.99T
Revenue Growth
+8.51%
P/S Ratio
2.82
Revenue / Employee
1.58B
Employees
1,257
Market Cap
5.62T
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.89T | 148.83B | 8.57% |
| Dec 31, 2023 | 1.74T | -2.06B | -0.12% |
| Dec 31, 2022 | 1.74T | -487.52B | -21.90% |
| Dec 31, 2021 | 2.23T | 232.03B | 11.63% |
| Dec 31, 2020 | 1.99T | 766.49B | 62.42% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PT Kalbe Farma Tbk. | 34.38T |
| PT Enseval Putera Megatrading Tbk. | 32.20T |
| PT Medela Potentia Tbk | 14.87T |
| PT Siloam International Hospitals Tbk | 12.51T |
| PT Soho Global Health Tbk | 10.51T |
| PT Kimia Farma Tbk | 9.08T |
| PT Lippo Karawaci Tbk | 8.56T |
| PT Sejahteraraya Anugrahjaya Tbk | 3.30T |